Download Vaccination to prevent cervical cancer – offered to all girls in grade 7

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Thiomersal controversy wikipedia , lookup

Globalization and disease wikipedia , lookup

Herd immunity wikipedia , lookup

Cysticercosis wikipedia , lookup

Vaccination policy wikipedia , lookup

Whooping cough wikipedia , lookup

Immunocontraception wikipedia , lookup

Vaccine wikipedia , lookup

Human papillomavirus infection wikipedia , lookup

Childhood immunizations in the United States wikipedia , lookup

Vaccination wikipedia , lookup

HPV vaccines wikipedia , lookup

Gardasil wikipedia , lookup

Transcript
AboutHPV-vaccination
inTheNorwegianChildhoodImmunisationProgramme
InformationforchildrenandparentsinEnglish
Vaccinationtopreventcervicalcancer
–offeredtoallgirlsingrade7(age12-13)
Textisbasedonthebrochure:OmHPV-vaksinenIbarnevaksinasjonsprogrammet
publishedbytheNorwegianInstituteofPublicHealth
Photo:colourbox.com
ENGLISH
2
THENORWEGIANIMMUNISATIONPROGRAMME•CHILD/PARENTINFORMATION
VACCINEAGAINSTHPV
LASTUPDATEDSEPTEMBER2014
_________________________________________________________________________________________________________
AllgirlsinNorwayingrade7(age12-13)areofferedhumanpapillomavirus(HPV)
vaccination.AsinthecaseofallvaccinesintheNorwegianChildhoodImmunisation
Programme,thisisanofferyoucanchoosetoaccept.Girlsshouldbewellinformedaboutthe
vaccine,andparentsshouldtaketheirwishesintoaccount.Pleasereadanddiscussthe
contentsofthisbrochurewithyourdaughter.
ThispublicationgivesyouinformationaboutcervicalcancerandhowtheHPVvaccineoffers
protectionforyounggirlsagainstdiseaselaterinlife.Thebrochureexplainshowthevaccineis
givenandprovidesinformationaboutitspotentialsideeffects.Formoreinformationabout
HPVandtheHPVvaccine,talktoyourschoolnurseorconsulttheNorwegianInstituteofPublic
Healthwebsite:www.fhi.no/vaksine
CERVICALCANCERISCAUSEDBYAVIRUS
Canceroftheneckofthewomb(cervix)iscausedbyaviruscalledhumanpapillomavirus(HPV).
TherearemanytypesofHPVvirus.Eachtypehasitsownnumber.Atleast12HPVtypescancause
cervicalcancer.ThecommonestonesthatcausecancerareHPV16andHPV18.InNorway,thesetwo
typesofviruscauseabout70percentofallcervicalcancers.
HPVinfectioniseasilycontractedfromsexualcontactanddoesnotusuallycausesymptoms.Most
womencontractanHPVinfectionatsomestageintheirlives,andusuallyatayoungage.
Inmostcases,HPVinfectionsresolveoftheirownaccord.Butifaninfectionwithcancer-causingHPV
lastsalongtime,itmayprogresstoprecancerouschangesinthecellsliningthecervix(dysplasia).
Theseprecancerouschangesmaydevelopintocervicalcancer.Seethefigureofthecervix.
Illustration:KariToverud
ENGLISH
THENORWEGIANIMMUNISATIONPROGRAMME•CHILD/PARENTINFORMATION
VACCINEAGAINSTHPV
LASTUPDATEDSEPTEMBER2014
___________________________________________________________________________________________________________
Ill
ABOUTCERVICALCANCER
Cervicalcancerisalife-threateningdisease.Eachyear,around300womeninNorwayarediagnosed
withthedisease,and65-100womendieofthiscancer.Eachyear,around3000womenhavesurgery
forseriousprecancerouschangesinordertopreventprogressiontocancer.Pregnantwomenwho
havehadsuchsurgeryhaveahigherriskofmiscarriageorprematurebirth.
Theprogressiontocervicalcancertypicallytakes10-30years.Somearediagnosedwithcervical
cancerwhentheyareyoung,andjustunder30%ofthosediagnosedareundertheageof45.
ABOUTGENITALWARTS
SometypesofHPVmaycausewartsaroundthegenitals/anus,butthesetypesdonotcausecancer.
Genitalwartsoftenresolvewithouttreatment.Theycanalsobetreated.Almostallcasesofgenital
wartsarecausedbyHPV6or11.
HOWTHEHPVVACCINEPROVIDESPROTECTION
TheHPVvaccinehasapreventiveeffectandshouldbegiventogirlsbeforethereisanyriskof
infection.ThisiswhytheNorwegianChildhoodImmunisationProgrammeoffersHPVvaccinationto
girlswellbeforetheNorwegianaverageageoffirstsexualactivity.
TheHPVvaccineprotectsagainstHPV16and18andtheprecancerouschangescausedbythesetwo
typesofHPV.Thevaccinedoesnotprotectagainstothercancer-causingtypesofHPV.
Cervicalcancerisalwaysprecededbyprecancerouschanges.Becausecancertakesalongtimeto
develop,itmaybe10-30yearsbeforetheprotectiveeffectoftheHPVvaccineagainstcervicalcancer
canbefinallyconfirmed.
TheHPVvaccinegivenintheNorwegianChildhoodImmunisationProgramme(Gardasil®)also
providesprotectionagainstgenitalwartscausedbyHPV6and11.
Thevaccineprovidesmorethan95%protectionagainstHPV6,11,16and18.
Thefirstgirlsgiventhevaccinealmosttenyearsagoarestillwellprotected.Thevaccineislikelyto
providelong-term,perhapslifelong,protection.Follow-upovertimeofthosethathavebeen
vaccinatedwillindicatewhetheraboosterdoseisneededlaterinlifetoprolongtheprotection.
HOWTHEVACCINEISGIVEN
Thevaccineisgivenover6–12months.Theseconddoseisusuallygiven2monthsafterthefirstone,
andthelastdoseisgiven6monthsafterthefirst.
Beforethevaccination,thenursewillaskifyouarehealthyandifyouhavehadreactionstoprevious
vaccines.Remembertotellthenurseifyouhaveallergies,takemedicinesorhaveotherhealth
problems.
Youcansafelybevaccinatedevenifyouhaveacoldorarelessfitthanusual.However,vaccinationis
usuallypostponedifyouareacutelyillorhaveafeverofmorethan38degrees.
Somegirlsfindithurtsabitandisuncomfortabletohavethevaccine,andafewmayfaint.Ifyouare
worriedaboutthis,orhavepreviouslybecomeunwellfromvaccination,youcanaskifyoucanlie
downwhenthevaccineisgiven.Aswithallothervaccines,youmustbesupervisedbythenursefor
about20minutesafterbeinginjected.All vaccination is voluntary.
ENGLISH
THENORWEGIANIMMUNISATIONPROGRAMME•CHILD/PARENTINFORMATION
VACCINEAGAINSTHPV
LASTUPDATEDSEPTEMBER2014
___________________________________________________________________________________________________________
SIDEEFFECTSANDSAFETY
TheHPVvaccinehasundergonelarge-scaleinternationaltrialsandisapprovedbytheNorwegian
MedicinesAgency.Thisapprovalisbasedonathoroughevaluationofthebenefitsandrisksofthe
vaccines.
ThecommonestsideeffectsofthevaccineintheNorwegianChildhoodImmunisationProgramme
(Gardasil)are:
•
•
Swelling,sorenessofthearmatthesiteoftheinjection,headache(morethan1in10ofthose
vaccinated).
Fever,nausea,paininthearm(morethan1in100).
Thesesymptomsdisappearafterafewdays.
Anyvaccinecaninrarecasescauseanallergicreactionsuchasarashoritchingshortlyafterthe
vaccinewasgiven.Inrarecases,vaccinescancausemoreseriousallergicreactions.Healthcare
personnelwhogivevaccinesarepreparedtodealwiththistypeofreaction.
Apartfromsomeveryrareallergicreactions,ithasnotbeendocumentedthatHPVvaccinehascaused
seriousdisease.Extremelyrareside-effectscannotbecompletelyexcludedandmaynotbediscovered
untilalargenumberofpeoplehavebeengivenanewmedicinalproduct.Allsevereandunexpected
symptomsoccurringaftervaccinationmustbereportedtotheNorwegianMedicinesAgency.The
reportsareexaminedtodetermineifthesymptomswerecausedbythevaccineorbytheonsetofa
diseasecoincidingwiththevaccination.
Symptomsexperiencedaftervaccinationarenotnecessarilyareactiontothevaccine,butmaybesigns
ofadiseaserequiringmedicalattention.Forthisreason,youshouldcontactyourdoctorifyouhave
concerns.
REGISTRATIONINTHENORWEGIANIMMUNISATIONREGISTRY
YourHPVvaccinationisrecordedinthevaccinator'ssystemandintheNorwegianImmunisation
Registry(SYSVAK).Toseewhichvaccinesyouoryourchildhavehad,usetheMinevaksinerserviceat
www.helsenorge.no.
REGULARCERVICALCANCERSCREENINGPROGRAMME
AllwomeninNorwayareinvitedtohaveacervicalsmeartestorpapsmearevery3yearsfromtheage
of25.Theaimofthisistoreducethenumberofdeathsfromcervicalcancerbyearlydetectionof
cancerorprecancerouschanges.TheNorwegianscreeningprogrammehasresultedinasignificant
decreaseinthenumberofcasesofcervicalcancer.
ItisimportantthatgirlsandwomenwhohavebeenvaccinatedagainstHPVparticipateinthe
screeningprogramme.ThisisbecausethevaccinesdonotprovideprotectionagainstallcancercausingtypesofHPV,anditisnotyetknownhowlongthevaccineswillprovideprotection.
Inaddition,othertypesofcancer-causingHPVmightpossiblybeamoresignificantcauseofcancer
thanthetwotypesthevaccineprotectsagainst.Theaimisforvaccinationandregularcervical
screeningtoprovidethebestpossibleprotectionagainstcervicalcancer.
ResearchisunderwaytomonitorhowtheimmunisationprogrammeaffectstheincidenceofHPV
infectionandcervicalcancerinNorway.TheNorwegianInstituteofPublicHealthisresponsiblefor
thefollow-upprogramme.
ENGLISH
THENORWEGIANIMMUNISATIONPROGRAMME•CHILD/PARENTINFORMATION
VACCINEAGAINSTHPV
LASTUPDATEDSEPTEMBER2014
___________________________________________________________________________________________________________
GOODTOKNOW:
•
•
•
•
•
•
•
TheWorldHealthOrganization(WHO)recommendsthatHPVvaccinationisincludedin
nationalchildhoodimmunisationprogrammes.HPVvaccineisincludedinthechildhood
immunisationprogrammeinanumberofcountries.
205milliondosesoftheHPVvaccineGardasilhavebeendistributedworldwide(December
2015).
TheHPVvaccineconsistsofartificiallymanufacturedparticlesresemblingpartsofthe
surfaceofHPV.Thevaccineisnotlive,doesnotcontainviralDNAandcannotcauseHPV
infection.
Novaccines,includingtheHPVvaccine,intheNorwegianChildhoodImmunisation
Programmecontainmercuryasapreservingagent.
AcondomdoesnotprovideadequateprotectionagainstHPVinfectionbecausethevirusis
alsofoundonareasofskinnearthegenitals,whichacondomdoesnotcoverorprotect.
TheHPVvaccineprovidesnoprotectionagainstothersexuallytransmitteddiseases.A
condomisalsoimportantforthosewhohavehadtheHPVvaccine.
TheNorwegianInstituteofPublicHealthhasrecommendedthatboys,likegirls,beoffered
theHPVvaccineundertheNorwegianChildhoodImmunisationProgramme.This
recommendationiscurrently(May2016)awaitingaparliamentaryhearing.
ENGLISH